Akari Therapeutics Rises: Investing in Anti-Inflammatory Breakthroughs
Akari Therapeutics PLC’s Nasdaq rebound shows its growing influence in anti‑inflammatory drug development for autoimmune and inflammatory diseases, fueling investor interest.
2 minutes to read
